Beta
Thioridazine
medication Under reviewA first-generation phenothiazine antipsychotic medication used primarily for the treatment of schizophrenia.
Research summary
Scientific evidence on thioridazine in healthy human subjects is extremely limited, with only one small pharmacokinetic study examining a single dose for hematopoietic progenitor cell mobilization, which found it well-tolerated but ineffective for short-term therapeutic use. No studies demonstrate benefits for general health, cognitive enhancement, or other supplement-like applications in healthy individuals, and its primary role remains psychiatric treatment rather than supplementation. Consensus highlights its pharmacological properties but cautions against non-medical use due to risks.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!